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One must demand an accurate, safe, radiation-free, and noninvasive method for reﬂux examination as the ideal possibility for
reﬂux screening. Of course the available diﬀerent imaging modalities are far from this ideal situation, but minimal radiation
exposure is indeed a permanent objective. Additionally since all of these studies might be quite stressful to the child and the family,
a specially designed and equipped environment is obligatory for the comfort of all involved. An absolute ideal modality in the
diagnosis of VUR would be the deﬁnition of a certain marker in serum or urine that could identify children with VUR without
the need for any interventional screening modality. Therefore more and more eﬀorts have to be made in the future to investigate
diﬀerent markers for this purpose. Since reﬂux is one of the most frequent congenital conditions pediatric urologist have to deal
with potential risks that might lead to renal insuﬃciency, noninvasive and radiation-free modalities should become the methods
of choice, hopefully in the near future.
Copyright © 2008 Christian Radmayr. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Diﬀerent imaging modalities for evaluating vesicoureteral
reﬂux (VUR) are nowadays available and more and more
attentionispaidtoconcernsaboutradiationsafety,especially
when multiple imaging studies are necessary with repeat
exposition to ionizing radiation during a conservative follow
up. Minimal radiation exposure is now a permanent objec-
tive.
Experience and logistic availability are often responsible
for choosing the one or the other imaging study. Moreover,
patient age,gender,race,andparentalpreferenceand anxiety
about invasiveness and radiation exposure play an additional
role as well.
In the past years, diﬀerent innovative techniques like
low-dose ﬂuoroscopy have deﬁnitively decreased radiation
dose to the patient. On the other hand, diagnostic quality
images are mandatory for appropriate diagnosis and treat-
ment. Ultrasonography, nuclear medicine, and magnetic
resonance are preferred to intravenous urography and com-
puted tomography whenever possible. In general, voiding
cystourethrography has frequent indications in pediatric
urology and eﬀorts are made to replace it by radionuclide
cystograms or sonocystograms in order to reduce the expo-
sure to ionizing radiation.
Furthermore, there is also no consensus about the timing
of evaluation for possible reﬂux as well as in the conservative
follow up or after intervention.
2. VOIDING CYSTOURETHROGRAPY, RADIONUCLIDE
CYSTOGRAPHY, SONOCYSTOGRAPHY
All these three modalities can be used to demonstrate
the presence or absence of VUR. Voiding cystourethro-
grapy (VCUG) as well as direct radionuclide cystography
(RNC) are invasive diagnostic tools with the need for
patient preparation and catheterization and the exposition
of the patient to ionizing radiation although VCUG is
a ﬂuoroscopic examination and RNC a nuclear medicine
study, respectively. Additionally, an indirect RNC with
the intravenous administration of technetium-99m-labeled
diehtylenetriamine pentaacetic acid is a possible tool with
the assumption of a possible VUR when radioisotope counts
increaseintherenalareasaftervoiding.Butthefalsenegative
rates may vary between 22 to 51% [1].
Eventhoughbeinginvasiveaswellsincecatheterizationis
mandatory, the big advantage of performing a sonocystogra-
phy is the prevention of any ionizing radiation to the patient
at all.2 Advances in Urology
For a conventional VCUG, a water soluble contrast
medium is instilled into the bladder after preparation
and transurethral sterile catheterization. An option is the
suprapubic administration of the contrast, but still invasive.
Diﬀerent ﬂuoroscopic images are taken to demonstrate the
presence or absence of vesicoureteral reﬂux.
The same procedure (preparation and catheterization) is
necessary for performing an RNC. Usually technetium 99m
pertechnetate is the radiopharmacon of choice to be instilled
into the bladder. The radioactive emissions are continuously
recorded with a gamma camera.
When comparing these two wide spread diagnostic
modalities, the big advantages of a classical VCUG are the
provision of high-resolution images with a clear evaluation
of the bladder wall, the urethra especially in males [2], any
sign of intrarenal reﬂux as well as a clear grading possibility.
It is also supplementary reliable for detecting duplication,
ureteral ectopia with or without ureteroceles, and posterior
urethral valves. That is why especially in boys and also for
the initial investigation in girls a classical VCUG is still the
preferred method of choice by many investigators. On the
other hand, the expense is a much higher dose of ionizing
radiation to the patient.
Although recent improvements introducing low-dose
ﬂuoroscopy techniques and pulse ﬂuoroscopy with the add
of digital enhancing modalities have decreased the radiation
dose to the patients dramatically [3–5], still a VCUG exposes
the patient to almost 100 times the radiation of an RNC.
A special concern is the quite high gonadal radiation dose
particularlywithmultiplestudiesofﬂuoroscopicmonitoring
[6].Ofcoursegonadalshieldinginmalesandcarefulimaging
coning help to decrease the patient’s radiation exposure.
Moreover, with the use of a low-dose ﬂuoroscopic system in
conjunction with a computer-based video frame grabber, the
ovarian radiation dose may become comparable to RNC [3].
A VCUG performed with an optimized pulsed ﬂuoroscope
canachieve“aslowasreasonablyachievable”(ALARA)levels
and of course maintain diagnostic image quality. With such
a setting radiation dosage can be reduced to 10% that of
continuous ﬂuoroscopy thus resulting in dosages at about 10
timesthatofRNC.Therefore,pulsedﬂuoroscopyiscurrently
the recommended standard [7, 8].
On the other hand, a direct RNC allows continuous
monitoring for VUR throughout the whole examination
timewithoutanyadditionalradiationintroduced.Therefore,
some authors prefer RNC to be more sensitive in the
diagnosis of VUR [9] although precise grading is impossible.
But this makes it probably an ideal methodology for the
conservative follow up and after any antireﬂux intervention.
The main advantage of RNC over ﬂuoroscopic VCUG is
deﬁnitively decreased radiation exposure of the patient. The
average eﬀective radiation dose of a VCUG using low-dose
ﬂuoroscopy is around 3mrem, compared to 0.5mrem for
an RNC. Of course the average eﬀective dose of the VCUG
is variable and depends on the patient size, operator, and
machinery [8]. The sensitivity of RNC for detecting reﬂux
is equal to or even greater than that of VCUG; however, the
spatial resolution and anatomic detail seen on an RNC are
ultimately inferior to those seen on a VCUG [10].
Sonocystography may be used as a very sensitive tool in
the detection of a possible VUR especially since the inter-
vention of various ultrasound echo enhancing agents [11].
First, attempts with this technology have been made back
in 1976. The capability of echo-enhanced reﬂuxsonography
extends further in that the method may enable complete
eliminationof any radiation exposure. This may justify the
longer examination time compared with that of VCUG.
Using an X-ray contrast agent, a certain concentration at
a given time is necessary to be able to see the contrast,
whereas even single microbubbles can be visualized with
the ultrasound method. This together with the duration of
the ultrasound examination as well might be responsible
for the detection of some low grade reﬂuxes that might be
missedusingVCUGandRNC.Moreover,thismethodallows
for cyclic ﬁllings without any additional radiation as well.
On the other hand, similar to RNC, the lack of diagnostic
visualization of anatomic details and particularly the urethra
represent a disadvantage of the ultrasound methodology.
Additionally, the interobserver variability might be quite
high and a specially trained examiner is obligatory. In
summary, of the available literature on that issue, the
comparative aggregated data between sonocystography and
VCUG indicate that reﬂux exclusion and diagnosis between
thetwomethodsishighlyconcordantandthatthediscordant
ﬁndings are primarily due to more reﬂux episodes being
detected solely by sonocystography and that these reﬂux
episodes are of higher grade and consequently may be
clinically more relevant than the predominantely low grade
reﬂuxfoundonlyonVCUGandthatﬁnallythehighnegative
predictive value of sonocystography may have practical
consequences as it demonstrates that sonocystography may
be suitable for screening purposes [12, 13].
3. CONCLUSION AND FUTURE MODALITIES
One must demand an accurate, safe, radiation-free, and
noninvasive method for reﬂux examination as the ideal
possibilityforreﬂuxscreening.Additionally,sinceallofthese
studies might be quite stressful to the child and the family a
specially designed and equipped environment is obligatory
for the comfort of all involved. Preparation and education of
the families help to reduce discomfort. If needed, sedation
with the use of midazolam can be beneﬁcial without any
negative inﬂuence on the outcome of the examination [14].
Contrast enhanced ultrasound allows an accurate and
safediagnosisandisinadditiontoVCUGandRNCradiation
free as well; but unfortunately, still an invasive procedure
with the insertion of a catheter. A future prospective might
be an exogenous bubble generation to fulﬁl one of the most
important criteria in reﬂux diagnosis: being noninvasive.
Eﬀorts are already being made to achieve this goal. Till then
nuclear medicine studies and contrast studies will remain
essential for the evaluation of VUR.
An absolute ideal modality in the diagnosis of VUR
would be the deﬁnition of a certain marker in serum or urine
thatcouldidentifychildrenwithVUR.Basicresearchisgoing
on to investigate diﬀerent markers that have been found
to be elevated in children with VUR [15]. Measured levelsChristian Radmayr 3
of microproteinuria, urine retinol-binding protein, urinary
prostaglandine E2, urinary β2-microglobulin, urinary inter-
leukin levels, and serum endothelium leukocyte adhesion
molecule have been shown to be elevated in patients with
VUR compared to controls. So far, none of these methods
can localize which kidney is aﬀected by reﬂux nor can
they assess the grade but they probably oﬀer the potential
advantage of rapidly screening for VUR.
Another marker, β-hexosaminidase, has been shown to
be higher in patients with VUR and renal scarring [16].
Tamm-Horsefall protein (THP) is another high-molecular-
weight glycoprotein that is exclusively present in the kidney
and not secreted elsewhere. In children with intrarenal
reﬂux, it is also detectable in blood vessels and lymph
nodes. It is believed to accumulate from leakage of adjacent
ruptured tubules [17]. Interestingly, in a study on children
with surgically corrected VUR but no improvement on
renal function postoperatively, THP levels remained elevated
before and after surgery [18]. Still a lot of research has to be
undertaken to minimize or hopefully abandon the burden
of one of the widest used imaging modalities in pediatric
urology.
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